References
Krause K, Tanabe KT. A shifting paradigm in diagnosis and management of hepatic adenoma. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08580-w.
Nault JC, Couchy G, Balabaud C, et al. Molecular Classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation. Gastroenterology. 2017;152:880–894.
Farges N, Ferrerira S, Dokmak J, et al. Changing trends in malignant transformation of hepatocellular adenoma. Gut. 2011;60(1):85–89.
Ronot M, Bahrami S, Calderaro J, et al. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology. 2011;53(4):1182–1191.
Bunchorntavakul C, Bahirwani R, Drazek D, et al. Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther. 2011;34:664–74.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Kate Krause and Kenneth K. Tanabe declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Krause, K., Tanabe, K.K. ASO Author Reflections: Developing Personalized Care for Hepatocellular Adenoma Based on Subtype Classification. Ann Surg Oncol 27, 3339–3340 (2020). https://doi.org/10.1245/s10434-020-08681-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08681-6